Entia Biosciences Stock Last Dividend Paid
| ERGO Stock | USD 0.0002 0.00 0.00% |
Entia Biosciences fundamentals help investors to digest information that contributes to Entia Biosciences' financial success or failures. It also enables traders to predict the movement of Entia Pink Sheet. The fundamental analysis module provides a way to measure Entia Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Entia Biosciences pink sheet.
Entia |
Entia Biosciences Company Last Dividend Paid Analysis
Entia Biosciences' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Entia Biosciences has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Entia Fundamentals
| Return On Asset | -1.64 | |||
| Operating Margin | (4.40) % | |||
| Current Valuation | 235.63 K | |||
| Shares Outstanding | 33.66 M | |||
| Price To Earning | (0.50) X | |||
| Price To Sales | 0.89 X | |||
| Revenue | 265.47 K | |||
| Gross Profit | 173.97 K | |||
| EBITDA | (1.29 M) | |||
| Net Income | (1.4 M) | |||
| Cash And Equivalents | 76.05 K | |||
| Debt To Equity | (1.57) % | |||
| Current Ratio | 0.11 X | |||
| Book Value Per Share | (0.07) X | |||
| Cash Flow From Operations | (715.1 K) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 12.64 | |||
| Market Capitalization | 235.63 K | |||
| Total Asset | 439.14 K | |||
| Retained Earnings | (13.37 M) | |||
| Working Capital | (1.64 M) | |||
| Current Asset | 73 K | |||
| Current Liabilities | 1.71 M | |||
| Z Score | -52.2 | |||
| Net Asset | 439.14 K |
About Entia Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Entia Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Entia Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Entia Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Entia Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entia Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Entia Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entia Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entia Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entia Biosciences to buy it.
The correlation of Entia Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entia Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entia Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Entia Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Entia Pink Sheet
Entia Biosciences financial ratios help investors to determine whether Entia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entia with respect to the benefits of owning Entia Biosciences security.